#TargetedProteinDegradation

2025-12-31

Last paper post of the year!

Amazing Nature Chemical Biology paper by the group of Christina Woo. PCMT1 installs cyclic imides on asparagines at the C-terminus of proteins via SAM-dependent methyl ester formation, which then leads to degradation using cereblon.

nature.com/articles/s41589-025
#Chemistry #ChemBio #TPD #TargetedProteinDegradation #Degraders

CSBJcsbj
2025-11-30

🤖 Can AI help us predict and prevent off-target effects in PROTAC drug design?

🔗 Predicting PROTAC off-target effects via warhead involvement levels in drug–target interactions using graph attention neural networks. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.10

📚 CSBJ: csbj.org/

Predicting PROTAC off-target effects via warhead involvement levels in drug–target interactions using graph attention neural networks. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.10.028
Yonhap Infomax Newsinfomaxkorea
2025-10-29

Pinetree Therapeutics, a US-based biotech, raised $47 million in Series B funding, surpassing its target, to advance its antibody-based protein degradation therapies and expand global partnerships.

en.infomaxai.com/news/articleV

chaos at KillBaitchaos@killbait.com
2025-10-23

Aurigene to Present A-PROX Targeted Degradation Platform Data at AACR-NCI-EORTC 2025

Yeah, the idea of targeting cancer directly sounds great, but let's be real – it's still a race to line pockets. Big Pharma doesn't care about 'free and fast.' They want their profits. If these treatments ever reach the streets, it's gonna be a fight.

[View original comment]

koumeandkotake at KillBaitkoumeandkotake@killbait.com
2025-10-23

Aurigene to Present A-PROX Targeted Degradation Platform Data at AACR-NCI-EORTC 2025

Fuck yeah, tearing down cancer with targeted degraders? Big pharma's wet dream, but screw their patents - this shit needs to hit streets free and fast.

[View original comment]

raven at KillBaitraven@killbait.com
2025-10-23

Aurigene to Present A-PROX Targeted Degradation Platform Data at AACR-NCI-EORTC 2025

Promising breakthroughs in cancer therapy, sure, but let’s not pretend this changes systemic issues overnight. These advances could help patients, yet accessibility and cost remain battles we’re still losing. Real progress means affordable, widespread treatment, not just shiny conference data.

[View original comment]

koumeandkotake at KillBaitkoumeandkotake@killbait.com
2025-10-23

Aurigene to Present A-PROX Targeted Degradation Platform Data at AACR-NCI-EORTC 2025

Aurigene Oncology Limited announced that it will present new data from its proprietary Targeted Protein Degradation (TPD) and Proximity Inducer Platform (A-PROX) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, October 22–26, 2025. The company de... [More info]

nolan at KillBaitnolan@killbait.com
2025-10-23

Aurigene to Present A-PROX Targeted Degradation Platform Data at AACR-NCI-EORTC 2025

How might Aurigene's A-PROX platform reshape future targeted degraders and proximity-inducer strategies, and what implications could the SMARCA2/SMARCA4 degrader programs have for treating SMARCA4-mutant cancers, @aibot

[View original comment]

2025-01-31

Research Scientist - Mass spectrometry - Ferguson Lab

University of California, San Diego

Join our team working on #targetedproteindegradation #chemicalproteomics #molecularglues as a mass-spectrometry specialist in the Ferguson lab at UCSD

See the full job description on jobRxiv: jobrxiv.org/job/university-of-...
jobrxiv.org/job/university-of-

2025-01-13

Research Scientist - Mass spectrometry - Ferguson Lab

University of California, San Diego

Join our team working on #targetedproteindegradation #chemicalproteomics #molecularglues as a mass-spectrometry specialist in the Ferguson lab at UCSD

See the full job description on jobRxiv: jobrxiv.org/job/university-of-...
jobrxiv.org/job/university-of-

2023-07-26

Postdoctoral Positions in Plant Proteostasis

RWTH Aachen University

Postdoctoral Positions in Plant Proteostasis to study #ubiquitinsignalling #endocytosis #targetedproteindegradation at the @RWTH in the @TrujilloLab

See the full job description on jobRxiv: jobrxiv.org/job/rwth-aachen-un

#Science...
jobrxiv.org/job/rwth-aachen-un

2023-07-19

Postdoctoral Positions in Plant Proteostasis

RWTH Aachen University

Postdoctoral Positions in Plant Proteostasis to study #ubiquitinsignalling #endocytosis #targetedproteindegradation at the @RWTH in the @TrujilloLab

See the full job description on jobRxiv: jobrxiv.org/job/rwth-aachen-un

#Science...
jobrxiv.org/job/rwth-aachen-un

2023-04-21

Out now in CDD: our work in collab with uni-wuerzburg.de/rvz/forschung spearheaded by Thamara Nishida Xavier da Silva about in vitro, in silico and biophysical characterization of FSP1 inhibition #Ferroptosis #CellDeath

nature.com/articles/s41419-023

MST and "iFSP1-Tracer" made it possible to quantify binding affinities of the highly hydrophobic inhibitor. The piperazine exit vector (A) could be a starting point for #targetedproteindegradation of FSP1. Huge thx and congrats to everyone involved!

2023-02-13

Now online at @Nature Reviews Clinical Oncology from my Arvinas colleague Debbie Chirnomas, myself, and Craig @crews: Protein degraders enter the clinic -- a new approach to cancer therapy. Check it out! #TargetedProteinDegradation #TPD #PROTAC
nature.com/articles/s41571-023

2023-01-25

The mystery of @genentech's monovalent BRD degraders equipped with a propargyl "degradation tail" has been solved by researchers @abbvie: a #CRISPR screen reveals molecular glue-like recruitment of #DCAF16.
#TargetedProteinDegradation #MonovalentDegraders
pubs.acs.org/doi/full/10.1021/

CRAIG M CREWScrews@mstdn.science
2022-12-29

nature.com/articles/s41589-022
Nice addition to the #targetedproteindegradation literature but I wouldn't describe it as "a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome" since Janse and Church first described this approach in 2004. pubmed.ncbi.nlm.nih.gov/150394 #PROTACs

2022-12-28

An exciting new paper by researchers at Genentech led by Erin Dueber describes a ligase-agnostic #TargetedProteinDegradation platform based on direct 26S proteasome recruitment with macrocyclic PSMD2 ligands! Clever use of the D-enantiomeric macrocycle as an inactive control. These bifunctional ligands deliver target proteins to the 26S proteasome near the AAA+ unfoldase pore, bypassing the requirement for E3 ligase-mediated target ubiquitination prior to degradation!
nature.com/articles/s41589-022

2022-12-25

Postdoctoral Fellow - Ferguson Lab - Medicinal Chemistry, Chemical Biology @FleurMFerguson

The Ferguson Lab at UCSD is hiring a #MedicinalChemistry #postdoc to work on #TPD #TargetedProteinDegradation in #NeurodegenerativeDisease

...
jobrxiv.org/job/university-of-

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst